Search results
- 1.0538203 - ÚOCHB 2021 US eng A - Abstract
Hollinger, K. R. - Bell, B. J. - Šála, Michal - Dash, R. P. - Thomas, A. G. - Chaudhuri, A. - Kumar, A. - Lovell, L. - Wu, Y. - Rais, R. - Haughey, N. J. - Nencka, Radim - Rojas, C. - Slusher, B. S.
Development of a Neutral Sphingomyelinase 2 Inhibitor for the Treatment of Alzheimer's Disease.
Neurotherapeutics. Springer. Roč. 17, č. 3 (2020), s. 1313-1314. ISSN 1933-7213. E-ISSN 1878-7479.
[ASENT 2020 Annual Meeting /22./. 02.03.2020-05.03.2020, Bethesda]
Institutional support: RVO:61388963
Keywords : Alzheimer * neutral sphingomyelinase 2 * PDDC
OECD category: Organic chemistry
Permanent Link: http://hdl.handle.net/11104/0316304 - 2.0521256 - ÚOCHB 2020 US eng A - Abstract
Šnajdr, Ivan - Jančařík, Andrej - Tenora, Lukáš - Nedelcovych, M. - Alt, J. - Englert, J. - Rojas, C. - Le, A. - Elgogary, A. - Tan, J. - Monincová, Lenka - Pate, K. - Adams, R. - Ferraris, D. - Powell, J. - Majer, Pavel - Rais, R. - Slusher, B. S.
Prodrugs of 6-Diazo-5-oxo-L-norleucine (DON) with Enhanced CSF Delivery in Monkeys as a Potential Treatment for Glioblastoma.
Boulder Peptide Symposium 2019. Boulder: Boulder Peptide Society, 2019.
[Boulder Peptide Symposium 2019. 23.09.2019-26.09.2019, Boulder]
Institutional support: RVO:61388963
Keywords : DON * glioblastoma * prodrugs
OECD category: Medicinal chemistry
Permanent Link: http://hdl.handle.net/11104/0305888 - 3.0521237 - ÚOCHB 2020 GR eng A - Abstract
Šnajdr, Ivan - Jančařík, Andrej - Tenora, Lukáš - Nedelcovych, M. - Alt, J. - Englert, J. - Rojas, C. - Le, A. - Elgogary, A. - Tan, J. - Monincová, Lenka - Pate, K. - Adams, R. - Ferraris, D. - Powell, J. - Majer, Pavel - Rais, R. - Slusher, B. S.
Prodrugs of 6-Diazo-5-oxo-L-norleucine (DON) with Enhanced CSF Delivery in Monkeys as a Potential Treatment for Glioblastoma.
EFMC-ASMC’19. 8th EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry. Athens: European Federation for Medicinal Chemistry, 2019. s. 352.
[EFMC-ASMC’19. EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry /8./. 01.09.2019-05.09.2019, Athens]
Institutional support: RVO:61388963
Keywords : DON * glioblastoma * prodrugs
OECD category: Medicinal chemistry
Permanent Link: http://hdl.handle.net/11104/0305872 - 4.0500743 - ÚOCHB 2019 IL eng A - Abstract
Rais, R. - Jančařík, Andrej - Tenora, Lukáš - Šnajdr, Ivan - Nedelcovych, M. - Alt, J. - Englert, J. - Rojas, C. - Le, A. - Elgogary, A. - Tan, J. - Monincová, Lenka - Pate, K. - Adams, R. - Ferraris, D. - Powell, J. - Majer, Pavel - Slusher, B. S.
Discovery of 6-Diazo-5-oxo-L-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
Joint Prague-Weizmann Winter School on Drug Discovery 2018. Rehovot: Weizmann Institute of Science, 2018.
[Joint Prague-Weizmann Winter School on Drug Discovery 2018. 03.12.2018-07.12.2018, Rehovot]
Institutional support: RVO:61388963
Keywords : 6-diazo-5-oxo-L-norleucine * glioblastoma
OECD category: Medicinal chemistry
Permanent Link: http://hdl.handle.net/11104/0292775 - 5.0500719 - ÚOCHB 2019 CZ eng A - Abstract
Rais, R. - Jančařík, Andrej - Tenora, Lukáš - Šnajdr, Ivan - Nedelcovych, M. - Alt, J. - Englert, J. - Rojas, C. - Le, A. - Elgogary, A. - Tan, J. - Monincová, Lenka - Pate, K. - Adams, R. - Ferraris, D. - Powell, J. - Majer, Pavel - Slusher, B. S.
Discovery of 6-Diazo-5-oxo-L-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
Liblice 2018. 53rd Advances in Organic, Bioorganic and Pharmaceutical Chemistry. Praha: Czech Chemical Society, 2018. s. 128.
[Liblice 2018. Advances in Organic, Bioorganic and Pharmaceutical Chemistry /53./. 02.11.2018-04.11.2018, Lázně Bělohrad]
Institutional support: RVO:61388963
Keywords : 6-diazo-5-oxo-L-norleucine * glioblastoma
OECD category: Medicinal chemistry
Permanent Link: http://hdl.handle.net/11104/0292760